Suggestions
Timothy Anderson
Managing Director at Cowen Healthcare Investments
Timothy Anderson is a Managing Director at Blue Owl Capital and a member of the Healthcare Opportunities Investment Team.12 He focuses on investments in biotechnology, diagnostics, and digital medicine companies, and sits on the fund's Investment Committee.12
Career History
Prior to his current role at Blue Owl, Timothy had a significant tenure at Cowen Healthcare Investments:
- He was a co-founding member and Managing Director at Cowen Healthcare Investments, which was the predecessor to Blue Owl's healthcare investment arm.12
- Before his role at Cowen Healthcare Investments, he worked as a biotechnology investment banker at Cowen and Company.2
In October 2023, Blue Owl Capital announced an agreement to acquire funds managed by Cowen Healthcare Investments, including the team led by Timothy Anderson.3 This acquisition added approximately $1 billion in assets under management to Blue Owl's portfolio.
Board Positions
Timothy serves on several boards, demonstrating his extensive involvement in the healthcare and biotechnology sectors:
- Current board member of Lycia Therapeutics, F2G, Anaveon, Autobahn Therapeutics, and Scipher Medicine.12
- Previously served as a board member or observer for companies such as Tourmaline Bio, Vectiv Bio Holdings, Therachon, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology, and Compass Therapeutics.12
Education
Timothy received his BA in both Economics and Government & Legal Studies from Bowdoin College.12
His LinkedIn profile can be found under the username timothy-anderson-844a6119, as mentioned in the query.